Seed-stage startups. Q1 2023. Let's dig into the numbers.
All data from the now 36,000+ companies on the Carta cap table platform. Only U.S. data included (international folks - I hear your objections loud and clear. More to come on a global scale soon!)
𝗠𝗲𝗱𝗶𝗮𝗻 𝗽𝗿𝗲-𝗺𝗼𝗻𝗲𝘆 𝘃𝗮𝗹𝘂𝗮𝘁𝗶𝗼𝗻𝘀 Some wide variation here by industry. Fintech startups valuations are lagging the pack at around $10M. Pharma valuations are surging ahead (median $26M).
𝗠𝗲𝗱𝗶𝗮𝗻 𝗰𝗮𝘀𝗵 𝗿𝗮𝗶𝘀𝗲𝗱 Again, marketplaces take the short end here (~$1.6M median raised). Gaming startups rose a healthy $3.8M per round.
𝗧𝗼𝘁𝗮𝗹 𝗿𝗼𝘂𝗻𝗱𝘀 𝗿𝗮𝗶𝘀𝗲𝗱 Standard B2B SaaS took the most investor attention, as per usual. Good showings from Biotech and Cybersecurity however.
30+ charts detailing exactly where venture capital sits at the moment out tomorrow - sign up for our newsletter in the first comment to brighten you inbox with good data.
Happy Monday, y'all.
#cartadata #startups #seedstage #valuations #roundsize #fundraising #venturecapital
DISCLOSURE: This communication is on behalf of eShares, Inc. dba Carta, Inc. ("Carta"). This communication is for informational purposes only, and contains general information only. Carta is not, by means of this communication, rendering accounting, business, financial, investment, legal, tax, or other professional advice or services. This publication is not a substitute for such professional advice or services nor should it be used as a basis for any decision or action that may affect your business or interests. Before making any decision or taking any action that may affect your business or interests, you should consult a qualified professional advisor. This communication is not intended as a recommendation, offer or solicitation for the purchase or sale of any security. Carta does not assume any liability for reliance on the information provided herein. © 2026 Carta. All rights reserved. Reproduction prohibited.
